25 September
3PM London / 10AM New York
The Importer of Record (IoR) plays an essential role in the clinical supply chain, helping products arrive at their intended destination on schedule. However, the area is rife with complexities as regulations vary in different regions and countries. Any documentation errors can have serious consequences for products, clinical trials, and patients. When it comes to IoR, it is crucial not to try and go it alone – even if you think you have everything covered on paper. Ensuring smooth passage requires specialist knowledge and experience.
Speakers
Zayheda Khan, Oximio’s Chief Commercial Officer and Mark Woolf, Chief Strategy and Development Officer will be providing useful insights on IOR best practices and how to identify the main pain points. Throughout the course of the discussion, we will learn why complexities don’t necessarily have to mean delays. We will also cover real-world examples of common mistakes in IoR and how to avoid them to prevent delays to your clinical shipments.
IOR Key learnings:
- Understanding the role of IoR
- How to ensure compliance with requirements
- The importance of partnerships across borders
- Dos and Don’ts
- Challenges + examples
Now available for viewing: How to Navigate the Complexities of Importer of Record Services in Clinical Trials